Quantifying the tumor microenvironment: what is the next step to advance cancer immunotherapy?

“Identifying the cancer type and patient cohort that could potentially respond to an oncology drug is one of the most important questions in oncology drug development. Thus, profiling and quantifying the TME in a cancer type specific manner is critical.”

Please enter your email to access content Read now